Cyclopharm Limited (ASX:CYC)
Australia · Delayed Price · Currency is AUD 0.5350
-0.0350 (-6.14%)
Aug 11, 2026, 4:10 PM AEST
Cyclopharm Market Cap
Cyclopharm has a market cap or net worth of 71.86 million as of August 11, 2026. Its market cap has decreased by -34.69% in one year.
Market Cap
71.86M
Enterprise Value
72.97M
Revenue
32.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.54
ChartMarket Cap Chart
Since January 18, 2007, Cyclopharm's market cap has increased from 50.89M to 71.86M, an increase of 41.20%. That is a compound annual growth rate of 1.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 71.86M | -34.02% |
| Dec 30, 2025 | 108.91M | -38.17% |
| Dec 31, 2024 | 176.15M | -2.75% |
| Dec 29, 2023 | 181.14M | 66.37% |
| Dec 30, 2022 | 108.87M | -28.90% |
| Dec 30, 2021 | 153.13M | -23.69% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Saluda Medical | 151.21M |
| EMVision Medical Devices | 148.73M |
| Lumos Diagnostics Holdings | 118.05M |
| SomnoMed | 92.01M |
| Epiminder | 69.23M |
| Cleo Diagnostics | 45.25M |
| Compumedics | 44.95M |
| Nova Eye Medical | 44.15M |